SCHEMBL19000703

SCHEMBL19000703

Cc1cccc(C)c1Cn1ncc(Cl)c(Cl)c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 3/20 0.64
▸ HTT P42858 13/20 0.64
▸ ALDH1A1 P00352 12/20 0.64
▸ NPSR1 Q6W5P4 9/20 0.64
▸ LMNA P02545 5/20 0.64
▸ CYP1A2 P05177 2/20 0.64
▸ CYP2C19 P33261 2/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ SMN1; SMN2 Q16637 4/20 0.64
▸ RAB9A P51151 10/20 0.60
▸ POLB P06746 4/20 0.60
▸ MEN1 O00255 3/20 0.60
▸ KMT2A Q03164 3/20 0.60
▸ BLM P54132 1/20 0.60
▸ GPR35 Q9HC97 1/20 0.60
▸ MAPT P10636 8/20 0.58
▸ RECQL P46063 1/20 0.58
▸ MITF O75030 5/20 0.56
▸ PKM P14618 2/20 0.56
▸ TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18980129 0.86 RAB9A (0.69) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL19000701 0.84 NPSR1 (0.76) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL19011573 0.82 RAB9A (0.60) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL19000708 0.80 HTT (0.60) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL19000726 0.79 NPSR1 (0.61) HTTALDH1A1NPSR1LMNACYP1A2
SCHEMBL12218257 0.78 HTT (1.00) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL1691901 0.78 HTT (0.71) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL10642561 0.75 RAB9A (1.00) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL19000706 0.74 HTT (0.77) NPBWR1HTTALDH1A1NPSR1LMNA
SCHEMBL980058 0.73 HTT (0.60) HTTALDH1A1NPSR1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS BAK1, DCLRE1B, BLVRB NPBWR1 2859/4885HTT 4458/4885ALDH1A1 4273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback